Project Grant R01AG098151
Award Date 2/15/26
Completion Date 1/31/31
Dollars Obligated $1.3M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
West Lafayette, IN, USA
Similar Awards
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded Indiana University a $1.23 million Project Grant under the Aging Research program (CFDA 93.866) to develop artificial intelligence-driven virtual screening pipelines for identifying brain-penetrant drug candidates targeting Alzheimer's disease and related dementias (AD/ADRD). The five-year project, running from February 1, 2026, through January 31, 2031, will deliver computational tools and datasets designed to...
- Federal Project Grant Award Summary Purdue University received a $419,005 Project Grant from the National Institute on Aging (CFDA 93.866, Aging Research program) awarded May 15, 2025, with a completion date of April 30, 2027. The grant supports research investigating the epigenome-metabolism nexus as a driver of circadian disruption in Alzheimer's disease. The project examines how alterations in one-carbon metabolism—specifically changes in S-adenosylmethionine (SAM) and...
- Federal Grant Award Summary The University of North Carolina at Chapel Hill received a $1.25 million Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866) to develop an integrated artificial intelligence (AI)-driven computational and experimental workflow for accelerating small-molecule drug discovery targeting Alzheimer's disease. The award, effective February 15, 2026 through January 31, 2031, supports research aimed at identifying chemical probes...
- Federal Grant Award Summary Purdue University received a $412,632 Project Grant from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859), effective August 1, 2025 through July 31, 2030. The award supports the development of advanced computer-aided synthesis planning (CASP) tools that integrate artificial intelligence with biocatalytic and chemo-enzymatic synthesis methods to accelerate the discovery and production of...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded a $615,390 Project Grant to the University of California, San Diego, effective February 1, 2026, through January 31, 2031, under the Aging Research program (CFDA 93.866). This grant supports the development of advanced artificial intelligence (AI) models capable of zero-shot antibody affinity predictions for anti-aging therapeutic applications. The research initiative addresses a critical gap in current AI-driven...
- Federal Grant Award Summary The University of South Florida received a $3.3 million Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866) effective September 1, 2025 through August 31, 2029. This award supports the development of novel peptidomimetic biomaterials designed to inhibit amyloid-beta (Aβ42) aggregation as a therapeutic intervention for Alzheimer's disease. The primary deliverables include the rational design and synthesis of structurally...
- Federal Project Grant Award Summary Duke University's Office of Research Administration was awarded $509,413 by the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) on September 15, 2025, for a project period extending through May 31, 2030. The award supports scientific research investigating epitranscriptomic regulation of microglia in Alzheimer's disease (AD), specifically examining how m6A (N6-methyladenosine) modifications of messenger RNA control microglial...
- Federal Grant Award Summary Northeastern University received a $2.24 million Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866) awarded on May 15, 2025, with completion anticipated by February 28, 2030. The grant funds comprehensive proteogenomic profiling research to identify and characterize aberrant and mis-processed proteins in Alzheimer's disease (AD) and tauopathy models. The research integrates advanced proteomic methods with...
- Federal Project Grant Award Summary The National Institute on Aging awarded Washington University a $3.19 million Project Grant (CFDA 93.866 - Aging Research) beginning September 1, 2025, and concluding August 31, 2029, to develop advanced machine learning methods for mapping relationships between Alzheimer's disease (AD) biomarkers and neuropsychiatric outcomes. The project will leverage in-vivo positron emission tomography (PET) imaging and magnetic resonance imaging (MRI) data to...
- Federal Grant Award Summary The University of Pittsburgh received a $664,619 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866) for the period January 1, 2026 through December 31, 2030. The award supports research to develop multiscale computational models of age-specific neurometabolic coupling—the relationship between neuronal activity and metabolic processes in the brain. This research addresses a critical gap in understanding metabolic...